![John Osth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Osth
Chief Executive Officer at QuantumCor, Inc.
John Osth active positions
Companies | Position | Start | End |
---|---|---|---|
QuantumCor, Inc.
![]() QuantumCor, Inc. Medical SpecialtiesHealth Technology QuantumCor, Inc. is a medical device company developing Transcatheter Mitral Valve Repair (TMVR) technologies. The company was founded by John Osth and is headquartered in Laguna Hills, CA. | Chief Executive Officer | 01/01/2002 | - |
Chairman | 01/01/2002 | - | |
Founder | 01/01/2002 | - | |
Miragene Corp. | Director/Board Member | - | - |
Hematologics, Inc. | Chief Operating Officer | - | - |
The Marrow Foundation | Director/Board Member | - | - |
NanoSomiX, Inc.
![]() NanoSomiX, Inc. BiotechnologyHealth Technology NanoSomiX, Inc. is a company that specializes in non-invasive testing using brain-derived exosomes (BDE) to improve brain analytic tools for research and clinical applications. The company is based in Aliso Viejo, CA, and the CEO of the company is John Osth. BDEs are small vesicles that carry brain-produced biomarkers related to brain function and are released into the bloodstream. The company works with academic researchers and commercial companies to support ongoing research into biomarkers associated with various neurologic disorders and neurotrauma. The company provides a blood-based assay that is repeatable, cost-effective, and fits easily into a routine diagnostic or research environment. | Chief Executive Officer | - | - |
President | - | - |
Career history of John Osth
Former positions of John Osth
Companies | Position | Start | End |
---|---|---|---|
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Director/Board Member | 01/10/2003 | 14/12/2007 |
Celula, Inc.
![]() Celula, Inc. Medical/Nursing ServicesHealth Services Celula, Inc. provides diagnostic testing services. It develops innovative instruments for clinical diagnostics and biomedical research using advanced micro fluidics and other technologies. The company was founded in May 2005 by Philippe J. Marchand, Andy Katz and Haichuan Zhang and is headquartered in San Diego, CA. | Chief Executive Officer | 01/05/2008 | - |
President | 01/05/2008 | - | |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | - |
Desert Trail Consulting LLC | Corporate Officer/Principal | 01/01/1999 | - |
Training of John Osth
The University of Chicago | Masters Business Admin |
University of Illinois | Graduate Degree |
United States Naval Academy | Undergraduate Degree |
Statistics
International
United States | 12 |
Canada | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 4 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 9 |
---|---|
Chemokine Therapeutics Corp.
![]() Chemokine Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada. | Health Technology |
QuantumCor, Inc.
![]() QuantumCor, Inc. Medical SpecialtiesHealth Technology QuantumCor, Inc. is a medical device company developing Transcatheter Mitral Valve Repair (TMVR) technologies. The company was founded by John Osth and is headquartered in Laguna Hills, CA. | Health Technology |
Desert Trail Consulting LLC | |
Miragene Corp. | |
Hematologics, Inc. | |
The Marrow Foundation | |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Celula, Inc.
![]() Celula, Inc. Medical/Nursing ServicesHealth Services Celula, Inc. provides diagnostic testing services. It develops innovative instruments for clinical diagnostics and biomedical research using advanced micro fluidics and other technologies. The company was founded in May 2005 by Philippe J. Marchand, Andy Katz and Haichuan Zhang and is headquartered in San Diego, CA. | Health Services |
NanoSomiX, Inc.
![]() NanoSomiX, Inc. BiotechnologyHealth Technology NanoSomiX, Inc. is a company that specializes in non-invasive testing using brain-derived exosomes (BDE) to improve brain analytic tools for research and clinical applications. The company is based in Aliso Viejo, CA, and the CEO of the company is John Osth. BDEs are small vesicles that carry brain-produced biomarkers related to brain function and are released into the bloodstream. The company works with academic researchers and commercial companies to support ongoing research into biomarkers associated with various neurologic disorders and neurotrauma. The company provides a blood-based assay that is repeatable, cost-effective, and fits easily into a routine diagnostic or research environment. | Health Technology |
- Stock Market
- Insiders
- John Osth
- Experience